Prostate-specific antigen testing in black and white men

An analysis of medicare claims from 1991-1998

Ruth Etzioni, Kristin M. Berry, Julie M. Legler, Pamela Shaw

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Objectives. To describe the trends in prostate-specific antigen (PSA) use and associated cancer detection among black and white Medicare beneficiaries older than 65 years during the calendar period from January 1991 through December 1998. Methods. Medicare claims data were linked with cancer registry data from the Surveillance, Epidemiology and End Results program of the National Cancer Institute. Data from a 5% random sample of men without a diagnosis of prostate cancer were combined with data from prostate cancer cases diagnosed during the calendar period from 1991 to 1998. PSA tests conducted after a diagnosis of prostate cancer were excluded. Results. PSA use has stabilized among white men, reaching an annual rate of 38% by 1995 and remaining at this level through 1998. The annual rate of use among black men reached 31% by 1998, but was still increasing at that time. By 1996, at least 80% of tests in both blacks and whites were second or later tests. By the end of 1996, 35% of white men and 25% of black men were undergoing testing at least biannually or more frequently. In 1996, 83% of diagnoses in whites and 77% in blacks were preceded by a PSA test. Conclusions. Older black men lag slightly behind older white men in their use of the PSA test; however, annual testing rates in blacks have yet to stabilize. In both race groups, an overwhelming majority of diagnoses are associated with a PSA test, whether for screening or diagnostic purposes. Regular screening rates in blacks are substantially lower than in whites, but the regular screening rates are relatively low in both race groups. Should PSA screening prove efficacious, efforts to promote regular use among both black and white men will likely be needed.

Original languageEnglish (US)
Pages (from-to)251-255
Number of pages5
JournalUrology
Volume59
Issue number2
DOIs
StatePublished - Feb 19 2002
Externally publishedYes

Fingerprint

Insurance Claim Review
Prostate-Specific Antigen
Medicare
Prostatic Neoplasms
SEER Program
National Cancer Institute (U.S.)
hydroquinone
Registries
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Prostate-specific antigen testing in black and white men : An analysis of medicare claims from 1991-1998. / Etzioni, Ruth; Berry, Kristin M.; Legler, Julie M.; Shaw, Pamela.

In: Urology, Vol. 59, No. 2, 19.02.2002, p. 251-255.

Research output: Contribution to journalArticle

Etzioni, Ruth ; Berry, Kristin M. ; Legler, Julie M. ; Shaw, Pamela. / Prostate-specific antigen testing in black and white men : An analysis of medicare claims from 1991-1998. In: Urology. 2002 ; Vol. 59, No. 2. pp. 251-255.
@article{8e14f49826cf4960af2caaefa172d0bf,
title = "Prostate-specific antigen testing in black and white men: An analysis of medicare claims from 1991-1998",
abstract = "Objectives. To describe the trends in prostate-specific antigen (PSA) use and associated cancer detection among black and white Medicare beneficiaries older than 65 years during the calendar period from January 1991 through December 1998. Methods. Medicare claims data were linked with cancer registry data from the Surveillance, Epidemiology and End Results program of the National Cancer Institute. Data from a 5{\%} random sample of men without a diagnosis of prostate cancer were combined with data from prostate cancer cases diagnosed during the calendar period from 1991 to 1998. PSA tests conducted after a diagnosis of prostate cancer were excluded. Results. PSA use has stabilized among white men, reaching an annual rate of 38{\%} by 1995 and remaining at this level through 1998. The annual rate of use among black men reached 31{\%} by 1998, but was still increasing at that time. By 1996, at least 80{\%} of tests in both blacks and whites were second or later tests. By the end of 1996, 35{\%} of white men and 25{\%} of black men were undergoing testing at least biannually or more frequently. In 1996, 83{\%} of diagnoses in whites and 77{\%} in blacks were preceded by a PSA test. Conclusions. Older black men lag slightly behind older white men in their use of the PSA test; however, annual testing rates in blacks have yet to stabilize. In both race groups, an overwhelming majority of diagnoses are associated with a PSA test, whether for screening or diagnostic purposes. Regular screening rates in blacks are substantially lower than in whites, but the regular screening rates are relatively low in both race groups. Should PSA screening prove efficacious, efforts to promote regular use among both black and white men will likely be needed.",
author = "Ruth Etzioni and Berry, {Kristin M.} and Legler, {Julie M.} and Pamela Shaw",
year = "2002",
month = "2",
day = "19",
doi = "10.1016/S0090-4295(01)01516-3",
language = "English (US)",
volume = "59",
pages = "251--255",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Prostate-specific antigen testing in black and white men

T2 - An analysis of medicare claims from 1991-1998

AU - Etzioni, Ruth

AU - Berry, Kristin M.

AU - Legler, Julie M.

AU - Shaw, Pamela

PY - 2002/2/19

Y1 - 2002/2/19

N2 - Objectives. To describe the trends in prostate-specific antigen (PSA) use and associated cancer detection among black and white Medicare beneficiaries older than 65 years during the calendar period from January 1991 through December 1998. Methods. Medicare claims data were linked with cancer registry data from the Surveillance, Epidemiology and End Results program of the National Cancer Institute. Data from a 5% random sample of men without a diagnosis of prostate cancer were combined with data from prostate cancer cases diagnosed during the calendar period from 1991 to 1998. PSA tests conducted after a diagnosis of prostate cancer were excluded. Results. PSA use has stabilized among white men, reaching an annual rate of 38% by 1995 and remaining at this level through 1998. The annual rate of use among black men reached 31% by 1998, but was still increasing at that time. By 1996, at least 80% of tests in both blacks and whites were second or later tests. By the end of 1996, 35% of white men and 25% of black men were undergoing testing at least biannually or more frequently. In 1996, 83% of diagnoses in whites and 77% in blacks were preceded by a PSA test. Conclusions. Older black men lag slightly behind older white men in their use of the PSA test; however, annual testing rates in blacks have yet to stabilize. In both race groups, an overwhelming majority of diagnoses are associated with a PSA test, whether for screening or diagnostic purposes. Regular screening rates in blacks are substantially lower than in whites, but the regular screening rates are relatively low in both race groups. Should PSA screening prove efficacious, efforts to promote regular use among both black and white men will likely be needed.

AB - Objectives. To describe the trends in prostate-specific antigen (PSA) use and associated cancer detection among black and white Medicare beneficiaries older than 65 years during the calendar period from January 1991 through December 1998. Methods. Medicare claims data were linked with cancer registry data from the Surveillance, Epidemiology and End Results program of the National Cancer Institute. Data from a 5% random sample of men without a diagnosis of prostate cancer were combined with data from prostate cancer cases diagnosed during the calendar period from 1991 to 1998. PSA tests conducted after a diagnosis of prostate cancer were excluded. Results. PSA use has stabilized among white men, reaching an annual rate of 38% by 1995 and remaining at this level through 1998. The annual rate of use among black men reached 31% by 1998, but was still increasing at that time. By 1996, at least 80% of tests in both blacks and whites were second or later tests. By the end of 1996, 35% of white men and 25% of black men were undergoing testing at least biannually or more frequently. In 1996, 83% of diagnoses in whites and 77% in blacks were preceded by a PSA test. Conclusions. Older black men lag slightly behind older white men in their use of the PSA test; however, annual testing rates in blacks have yet to stabilize. In both race groups, an overwhelming majority of diagnoses are associated with a PSA test, whether for screening or diagnostic purposes. Regular screening rates in blacks are substantially lower than in whites, but the regular screening rates are relatively low in both race groups. Should PSA screening prove efficacious, efforts to promote regular use among both black and white men will likely be needed.

UR - http://www.scopus.com/inward/record.url?scp=0036166841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036166841&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(01)01516-3

DO - 10.1016/S0090-4295(01)01516-3

M3 - Article

VL - 59

SP - 251

EP - 255

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -